Dirk Nagorsen

This inventor holds 11 USPTO granted patents, plus 5 CIPO patents and 7 EPO patents. Top assignees: Amgen Research (Munich) Gmbh, Micromet Ag. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Nagorsen. Retrieved from https://idiyas.com/inventor/dirk-nagorsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

CIPO Patents = 5

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 55(Granted Patents)

Company Filing History:

10 out of 77

Amgen Research (Munich) Gmbh

Years Active: 2014-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11633408 - Prevention of adverse effects caused by CD3 specific binding domains (2023-04-25),

2. 11579142 - Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at risk for potential adverse effects (2023-02-14),

3. 11084876 - Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains (2021-08-10),

4. 10696744 - Means and methods for treating DLBCL (2020-06-30),

5. 10662243 - Dosage regimen for administering a CD19XCD3 bispecific antibody (2020-05-26),

6. 10191034 - Dosage regimen for administrating a CD19×CD3 bispecific antibody to patients at risk for potential adverse effects (2019-01-29),

7. 10130638 - Prevention of adverse effects caused by CD3 specific binding domains (2018-11-20),

8. 9688760 - Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains (2017-06-27),

9. 9486475 - PPS for the prevention of potential adverse effects caused by CD3 specific binding domains (2016-11-08),

10. 9192665 - Means and methods for treating DLBCL (2015-11-24),

11. 8840888 - Dosage regimen for administering a CD19XCD3 bispecific antibody (2014-09-23),

Title: Dirk Nagorsen - Innovative Inventor from Munich

Introduction: Dirk Nagorsen is a renowned inventor based in Munich, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Dirk Nagorsen holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Dirk Nagorsen has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Dirk Nagorsen has collaborated with top universities, multinational corporations, and innovative startups to bring his ideas to life and make a lasting impact on the world of innovation.

Conclusion: Dirk Nagorsen's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.